Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

White Iris leukocyte differential analyzer cleared for U.S. market

Aug. 9, 1996

OncorMed to offer genetic testing for BRC2 mutations

Aug. 9, 1996

BRACAone undergoes beta-site testing in U.S.

Aug. 9, 1996

Cyogen's ProstaScint on its way to FDA approval

July 26, 1996

Oncor obtains license to p43 blood test for early-stage breast cancer

July 26, 1996

ICD grants exclusive rights of DR-70 to Y.H. BioTek

July 26, 1996

Quidel's QuickVue Chlamydia Test approved in Germany

July 26, 1996

Contrast agents and antidotes described by Schering AG

July 26, 1996

Positive phase I/II trial results for Parkinson's diagnostic, Altropane

July 19, 1996

Neoprobe's RIGScan CR49 undergoes European review

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.